Mitxelena, Asier, and Maria Areses. “Bezlotoxumab Can Reduce the Risk of Clostridium Difficile Recurrence”. Osagaiz: osasun-zientzien aldizkaria 6, no. 1 (July 29, 2022). Accessed November 11, 2026. https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/362.